MARKET

INBX

INBX

Inhibrx Biosciences Inc
NASDAQ
12.41
-0.93
-6.97%
Opening 11:43 04/07 EDT
OPEN
12.97
PREV CLOSE
13.34
HIGH
14.00
LOW
12.10
VOLUME
151.77K
TURNOVER
--
52 WEEK HIGH
18.95
52 WEEK LOW
10.80
MARKET CAP
179.65M
P/E (TTM)
0.1102
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at INBX last week (0331-0404)?
Weekly Report · 3h ago
Inhibrx Biosciences Appoints New President Amid Leadership Changes
TipRanks · 5d ago
Inhibrx appoint Carlos Bais as Chief Scientific Officer
TipRanks · 5d ago
INHIBRX BIOSCIENCES INC - ENTERS EXCLUSIVE LICENSE AGREEMENT WITH NEW COMPANY
Reuters · 5d ago
Weekly Report: what happened at INBX last week (0324-0328)?
Weekly Report · 03/31 12:47
Weekly Report: what happened at INBX last week (0317-0321)?
Weekly Report · 03/24 12:29
Inhibrx Biosciences GAAP EPS of -$3.09 misses by $0.21, revenue of $100K
Seeking Alpha · 03/17 20:29
INHIBRX BIOSCIENCES, INC. (Form 10-K)
Press release · 03/17 20:13
More
About INBX
More
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. The Company’s clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106. INBRX-109 is a tetravalent agonist of death receptor 5 (DR5) that is designed with its proprietary single domain antibody, or sdAb, platform to drive cancer-selective programmed cell death and to maximize potency while minimizing on-target liver toxicity arising from hepatocyte apoptosis. INBRX-106 is a hexavalent OX40 agonist, being investigated as a single agent and in combination with Keytruda, a PD-1 blocking checkpoint inhibitor, in patients with locally advanced or metastatic solid tumors. INBRX-106 is a precisely engineered hexavalent sdAb-based therapeutic candidate targeting OX40, designed to be an optimized agonist of this co-stimulatory receptor.
Recently
Symbol
Price
%Change

Webull offers Inhibrx Biosciences Inc stock information, including NASDAQ: INBX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INBX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INBX stock methods without spending real money on the virtual paper trading platform.